The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Increased bone marrow iron levels in patients with haematological malignancies is an independent risk factor for developing invasive pulmonary aspergillosis (IPA), suggesting an important role for iron uptake in the pathogenesis of IPA. We sought to determine the potential for combination therapy with the iron chelator deferasirox + liposomal amphotericin B (LAmB) to improve the outcome of murine IPA compared with LAmB monotherapy. METHODS: In vitro MIC and minimum fungicidal concentration (MFC) values of the iron chelator, deferasirox, for Aspergillus fumigatus were determined by microdilution assay. In addition, we studied the efficacy of deferasirox alone or combined with LAmB in treating immunocompromised mice infected with A. fumigatus via inhalation. RESULTS: Deferasirox was cidal in vitro against A. fumigatus, with an MIC and MFC of 25 and 50 mg/L, respectively. Deferasirox monotherapy modestly prolonged survival of mice with IPA. Combination deferasirox + LAmB therapy synergistically improved survival and reduced lung fungal burden compared with either monotherapy alone. CONCLUSIONS: Iron chelation therapy with deferasirox alone or in combination with LAmB is effective in treating experimental IPA. Further study of deferasirox is warranted as adjunctive therapy for IPA infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High iron modulates the gut microbiome [22]”
From High iron-mediated increased oral fungal burden, oral-to-gut transmission, and changes to pathogenicity of Candida albicans in oropharyngeal candidiasis (2022) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Invasive Aspergillosis in 2002: An Update
Kontoyiannis, D., & Bodey, G. (2002) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-002-0699-z · Cited by 326
The iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ibrahim, A. S., Gebermariam, T., Fu, Y., Lin, Husseiny, M. I., French, S. W., Schwartz, J., Skory, C. D., Edwards, J. E., & Spellberg, B. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32338 · Cited by 308
Self-citationHissen, A. H. T., Wan, A. N. C., Warwas, M. L., Pinto, L. J., & Moore, M. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.5493-5503.2005 · Cited by 243
Deferiprone iron chelation as a novel therapy for experimental mucormycosis
Ibrahim, A. S., Edwards, J. E., Fu, Y., & Spellberg, B. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl350 · Cited by 156
Self-citationKontoyiannis, D. P., Chamilos, G., Lewis, R. E., Giralt, S., Cortes, J., Raad, I. I., Manning, J. T., & Han, X. (2007) · Cancer · doi:10.1002/cncr.22909 · Cited by 152
Novel Inhalational Murine Model of Invasive Pulmonary Aspergillosis
Sheppard, D. C., Rieg, G., Chiang, L. Y., Filler, S. G., Edwards, J. E., & Ibrahim, A. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1908-1911.2004 · Cited by 133
Self-citationAltés, A., Remacha, A. F., Sardà, P., Sancho, F. J., Sureda, A. M., Martino, R., Briones, J., Brunet, S., Canals, C., & Sierra, J. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704628 · Cited by 128
Zarember, K. A., Cruz, A. R., Huang, C.-Y., & Gallin, J. I. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01547-08 · Cited by 78
Cited by
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
Cornely, O. A., Arikan-Akdagli, S., Dannaoui, E., Groll, A. H., Lagrou, K., Chakrabarti, A., Lanternier, F., Pagano, L., Skiada, A., Akova, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12371 · Cited by 863
Iron in infection and immunity
Nairz, M., & Weiss, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100864 · Cited by 359
HapX-Mediated Adaption to Iron Starvation Is Crucial for Virulence of Aspergillus fumigatus
Schrettl, M., Beckmann, N., Varga, J., Heinekamp, T., Jacobsen, I. D., Jöchl, C., Moussa, T. A., Wang, S., Gsaller, F., Blatzer, M., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001124 · Cited by 284
Iron - a key nexus in the virulence of Aspergillus fumigatus
Haas, H. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00028 · Cited by 217
Hsu, P.-C., Yang, C.-Y., & Lan, C.-Y. (2011) · Eukaryotic Cell · doi:10.1128/ec.00158-10 · Cited by 157
Iron homeostasis—Achilles’ heel of Aspergillus fumigatus?
Schrettl, M., & Haas, H. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.06.002 · Cited by 139
Yasmin, S., Alcazar-Fuoli, L., Gründlinger, M., Puempel, T., Cairns, T., Blatzer, M., Lopez, J. F., Grimalt, J. O., Bignell, E., & Haas, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106399108 · Cited by 126
“3β-ol, 4,4,14,24-tetramethylcholesta-8,24(28)-dien-3β-ol, 4α,24dimethylcholesta-7,24(28)-dien-3β-ol, and 4,4,24-trimethylcholesta-8,24(28)-dien-3β-ol.”
BackgroundInfluentialPagano, L., Cornely, O. A., Busca, A., Caira, M., Cesaro, S., Gasbarrino, C., Girmenia, C., Heinz, W. J., Herbrecht, R., Lass-Florl, C., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.083063 · Cited by 121
Leal, S. M., Roy, S., Vareechon, C., Carrion, S. D., Clark, H., Lopez-Berges, M. S., diPietro, A., Schrettl, M., Beckmann, N., Redl, B., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003436 · Cited by 111
Antifungal therapy in invasive fungal infections
Chen, S. C. ‐., Playford, E. G., & Sorrell, T. C. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.06.002 · Cited by 109
pH Signaling in Human Fungal Pathogens: a New Target for Antifungal Strategies
Cornet, M., & Gaillardin, C. (2014) · Eukaryotic Cell · doi:10.1128/ec.00313-13 · Cited by 98
Weinberg, E. D. (2010) · Metallomics · doi:10.1039/c0mt00023j · Cited by 81
An encapsulation of iron homeostasis and virulence in Cryptococcus neoformans
Kronstad, J. W., Hu, G., & Jung, W. H. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.05.007 · Cited by 78
L.S. Santos, A., L. Sodre, C., S. Valle, R., A. Silva, B., A. Abi-chacra, E., V. Silva, L., L. Souza-Goncalves, A., S. Sangenito, L., S. Goncalves, D., O.P. Souza, L., et al. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800609788 · Cited by 68
Ibrahim, A. S., Gebremariam, T., Luo, G., Fu, Y., French, S. W., Edwards, J. E., & Spellberg, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01577-10 · Cited by 63
Self-citationIron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies
Tyrrell, J., & Callaghan, M. (2016) · Microbiology · doi:10.1099/mic.0.000220 · Cited by 56
Desoubeaux, G., & Cray, C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00841 · Cited by 55
“Ibrahim et al. estimated a mean inhalation of only 2.1 × 103 conidia, when 1.2 × 1010 were nebulized in the chamber (Ibrahim et al., 2010, 2011).”
MethodInfluentialPitman, S. K., Drew, R. H., & Perfect, J. R. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.607811 · Cited by 54
Zinc Acquisition: A Key Aspect in Aspergillus fumigatus Virulence
Amich, J., & Calera, J. A. (2014) · Mycopathologia · doi:10.1007/s11046-014-9764-2 · Cited by 56
Iron Pathways and Iron Chelation Approaches in Viral, Microbial, and Fungal Infections
Chhabra, R., Saha, A., Chamani, A., Schneider, N., Shah, R., & Nanjundan, M. (2020) · Pharmaceuticals · doi:10.3390/ph13100275 · Cited by 58
Animal Models of Aspergillosis.
Désoubeaux, G., & Cray, C. (2018) · Europe PMC (PubMed Central) · Cited by 60
The crucial role of iron uptake in Aspergillus fumigatus virulence
Moore, M. M. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.07.012 · Cited by 56
Effects of Iron Chelators on the Formation and Development of Aspergillus fumigatus Biofilm
Nazik, H., Penner, J. C., Ferreira, J. A., Haagensen, J. A. J., Cohen, K., Spormann, A. M., Martinez, M., Chen, V., Hsu, J. L., Clemons, K. V., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01684-15 · Cited by 46
Stanford, F. A., & Voigt, K. (2020) · Genes · doi:10.3390/genes11111296 · Cited by 46
Laskaris, P., Atrouni, A., Calera, J. A., d'Enfert, C., Munier-Lehmann, H., Cavaillon, J.-M., Latgé, J.-P., & Ibrahim-Granet, O. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00324-16 · Cited by 37
Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia
Luo, G., Spellberg, B. J., Gebremariam, T., Lee, H., Xiong, Y. Q., French, S. W., Bayer, A. S., & Ibrahim, A. S. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2023-5 · Cited by 42
Self-citationHsu, J. L., Manouvakhova, O. V., Clemons, K. V., Inayathullah, M., Tu, A. B., Sobel, R. A., Tian, A., Nazik, H., Pothineni, V. R., Pasupneti, S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2616 · Cited by 38
Symeonidis, A. S., & Marangos, M. N. (2012) · InTech eBooks · doi:10.5772/34760 · Cited by 52
Newer combination antifungal therapies for invasive aspergillosis
Steinbach, W. J., Juvvadi, P. R., Fortwendel, J. R., & Rogg, L. E. (2010) · Medical Mycology · doi:10.3109/13693786.2010.499374 · Cited by 33
A computational model of invasive aspergillosis in the lung and the role of iron
Oremland, M., Michels, K. R., Bettina, A. M., Lawrence, C., Mehrad, B., & Laubenbacher, R. (2016) · BMC Systems Biology · doi:10.1186/s12918-016-0275-2 · Cited by 30
Invasive aspergillosis in liver transplant recipients
Melenotte, C., Aimanianda, V., Slavin, M. A., Aguado, J. M., Armstrong-James, D. P. H., Chen, Y., Husain, S., van Delden, C., Saliba, F., Lefort, A., et al. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14049 · Cited by 37
Holbein, B. E., Ang, M. T. C., Allan, D. S., Chen, W., & Lehmann, C. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-021-01242-7 · Cited by 28
Balhara, M., Chaudhary, R., Ruhil, S., Singh, B., Dahiya, N. R., Parmar, V. S., Jaiwal, P. K., & Chhillar, A. K. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1254196 · Cited by 31
Targeting zinc homeostasis to combat Aspergillus fumigatus infections
Vicentefranqueira, R., Amich, J., Laskaris, P., Ibrahim-Granet, O., Latgé, J. P., Toledo, H., Leal, F., & Calera, J. A. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00160 · Cited by 27
Antifungal adjuvants: Preserving and extending the antifungal arsenal
Butts, A., Palmer, G. E., & Rogers, P. D. (2017) · Virulence · doi:10.1080/21505594.2016.1216283 · Cited by 26
Leal, S. M., Roy, S., Vareechon, C., Carrion, S. D. J., Clark, H., López‐Berges, M. S., Pietro, A. D., Schrettl, M., Beckmann, N., Redl, B., et al. (2013) · PLoS Pathogens · doi:10.1371/annotation/4f388450-90fe-4c65-9b9b-71a2b7935ac0 · Cited by 27
Identification of Membrane Proteome of Paracoccidioides Lutzii and its Regulation by Zinc
de Curcio, J. S., Silva, M. G., Bailão, M. G. S., Báo, S. N., Casaletti, L., Bailão, A. M., & Soares, C. M. D. A. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0044 · Cited by 28
Petzer, V., Wermke, M., Tymoszuk, P., Wolf, D., Seifert, M., Ovaçin, R., Berger, S., Orth-Höller, D., Loacker, L., Weiss, G., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000043 · Cited by 22
Enfermedad fúngica invasora por Scedosporium, Fusarium y Mucor
Pemán, J., & Salavert, M. (2014) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2014.05.002 · Cited by 39
Recent advances in the treatment of life-threatening, invasive fungal infections
Drew, R. H., Townsend, M. L., Pound, M. W., Johnson, S. W., & Perfect, J. R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.838217 · Cited by 31
Stanford, F. A., Matthies, N., Cseresnyés, Z., Figge, M. T., Hassan, M. I. A., & Voigt, K. (2021) · Journal of Fungi · doi:10.3390/jof7040272 · Cited by 23
Michels, K. R., Solomon, A. L., Scindia, Y. M., Vieira, L. S., Goddard, Y., Whitten, S., Vaulont, S., Burdick, M. D., Atkinson, C., Laubenbacher, R., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac079 · Cited by 20
Micafungin alone and in combination therapy with deferasirox against Pythium insidiosum
Zanette, R. A., Jesus, F. P. K., Pilotto, M. B., Weiblen, C., Pötter, L., Ferreiro, L., Alves, S. H., & Santúrio, J. M. (2014) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2014.09.002 · Cited by 19
Iron chelation therapy as a treatment for Pythium insidiosum in an animal model
Zanette, R. A., Alves, S. H., Pilotto, M. B., Weiblen, C., Fighera, R. A., Wolkmer, P., Flores, M. M., & Santúrio, J. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks534 · Cited by 20
Hierro e infección fúngica invasiva
Álvarez, F., Fernández‐Ruiz, M., & Aguado, J. M. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.04.002 · Cited by 25
Tripathi, A., Nahar, A., Sharma, R., Kanaskie, T., Al-Hebshi, N., & Puri, S. (2022) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2044110 · Cited by 16
El tratamiento de la mucormicosis (cigomicosis) en el siglo xxi
Ruíz-Camps, I., & Salavert, M. (2018) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2018.09.001 · Cited by 20
Tuning the Anti(myco)bacterial Activity of 3-Hydroxy-4-pyridinone Chelators through Fluorophores
Rangel, M., Moniz, T., Silva, A. M. N., & Leite, A. (2018) · Pharmaceuticals · doi:10.3390/ph11040110 · Cited by 17
Valković, T., & Stanić, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154457 · Cited by 15
Mechanisms and regulation of iron uptake and the role of iron in pathogenesis of Candida albicans
Zheng, D., Zhang, X., Ding, J., Yue, D., Yang, F., & Li, Y. (2025) · Critical reviews in microbiology · doi:10.1080/1040841x.2025.2510256 · Cited by 10
Computational Modeling of Macrophage Iron Sequestration during Host Defense against Aspergillus
Adhikari, B., Scindia, Y. M., Vieira, L. S., Ribeiro, H. D. A. L., Masison, J., Yang, N., Fonseca, L. L., Wheeler, M., Knapp, A., Mei, Y., et al. (2022) · mSphere · doi:10.1128/msphere.00074-22 · Cited by 10
Hamad, M. A., & Awadallah, S. M. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.10.019 · Cited by 9
The Re-Emerging Role of Iron in Infection and Immunity
Hamad, M. A., & Bajbouj, K. (2016) · Integrative Molecular Medicine · doi:10.15761/imm.1000251 · Cited by 9
Itoh, K., Tsutani, H., Mitsuke, Y., & Iwasaki, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1210747 · Cited by 7
Treatment of Non-Aspergillus Mold Infections: a Focus on Mucormycosis and Fusariosis
Phoompoung, P., & Luong, M. (2019) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-019-00205-5 · Cited by 8
Sim, Y., & SeungWon, S. (2010) · Natural Product Sciences · Cited by 5
Ni, T., Chi, X., Wu, H., Xie, F., Bao, J., Wang, J., Ji, Z., Li, L., Wang, X., Yan, L., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116026 · Cited by 4
Shinohara, T., Wada, A., Abe, M., Oiki, S., Koizumi, A., Otani, A., Katano, H., & Miyazaki, Y. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00856-25 · Cited by 2
Tóth, Z., Farkas, B., Majoros, L., Jakab, Á., Borman, A. M., Varga, I., Tóth, P., & Kovács, R. (2025) · Medical Mycology · doi:10.1093/mmy/myaf116 · Cited by 3
Treatment of pulmonary mucormycosis: current concepts
Muthu, V., Sehgal, I. S., & Agarwal, R. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2622695 · Cited by 5
Techniques for mathematical analysis and optimization of agent-based models
Oremland, M. (2014) · VTechWorks (Virginia Tech) · Cited by 1
Lai, Y. (2016) · The Sydney eScholarship Repository (The University of Sydney)
Iron Uptake in Host Defense Against Pneumonia
Michels, K. R. (2017) · doi:10.18130/v3465h
Potential additional effects of iron chelators on antimicrobial-impregnated central venous cathetersPreprint
Itoh, K., Tsutani, H., Mitsuke, Y., & Iwasaki, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2118960/v1
Non-Aspergillus Pulmonary Mold Infections
Muthu, V., & Chakrabarti, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-76524-7_25
Mucormycosis and Entomophthoramycosis
Wattier, R. L., & Steinbach, W. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00223-5
Iron and the lung: emerging roles of iron metabolism in pulmonary disease pathogenesis and therapy
Galaris, A., Toumpanakis, D., Galaris, D., Vassilakopoulos, T., & Pantopoulos, K. (2026) · European Respiratory Review · doi:10.1183/16000617.0160-2026
Metadata
- Authors
- Ibrahim, A. S., Gebremariam, T., French, S. W., Edwards, J. E., & Spellberg, B.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Ibrahim, A. S.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-26
- Volume
- 65
- Issue
- 2
- Pages
- 289-292
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- PMC
- PMC2902852
- OpenAlex
- W2160870988
- Cited by
- 68
- References
- 9
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 3 · 2016: 6 · 2015: 3 · 2014: 6 · 2013: 11 · 2012: 3
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Gilead Sciences
- National Institute of Allergy and Infectious Diseases (R21AI064716, R01AI063503)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- deferasirox, liposomal amphotericin B, invasive pulmonary aspergillosis, Aspergillus fumigatus, iron chelation, combination antifungal therapy, antifungal synergy, immunocompromised patients, hematologic malignancies, bone marrow iron, antifungal susceptibility
- MeSH terms
- Deferasirox, Amphotericin B, Animals, Antifungal Agents, Aspergillus fumigatus, Benzoates, Drug Synergism, Drug Therapy, Combination, Humans, Male, Mice, Inbred BALB C, Microbial Sensitivity Tests, Triazoles, Survival Analysis, Treatment Outcome, Microbial Viability, Mice, Invasive Pulmonary Aspergillosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.